Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Home-Run Trial: Home-Based BCG Delivery for NMIBC
NCT07874347Phase 2Not yet recruiting
- Sponsor
- The Ohio State University Comprehensive Cancer Center – James Cancer Hospital
- Start
- Jan 2027
- Primary completion
- Dec 2028
- Countries
- 1
01
Overview
A Phase 2 trial of bcg vaccine in bladder carcinoma, sponsored by The Ohio State University Comprehensive Cancer Center – James Cancer Hospital. Planned start Jan 2027; status: not yet recruiting.
02
Drugs
bcg vaccine
03
Conditions
bladder carcinoma
Beyond the preview
Go deeper on NCT07874347.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07874347.